Inquiry into the Imclone Cancer-Drug Story Hearings Before the Committee on Energy and Commerce, U.S. House of Representatives

Witnesses: Lester Crawford, FDA; Robert Goldhammer, Chmn. of the Board, Paul Kopperl and John Mendelsohn, Members of the Board of Directors, and John Landes, Sr. V.P., Legal, ImClone Systems, Inc.; Patricia Keegan, FDA; Richard Pazdur, FDA; Lee Pai-Scherf, Clinical Reviewer, George Mills, Team Leader, and Susan Jerian, Medical Officer, FDA; Frank Papineau, Detailee, Committee on Energy and Commerce; Raymond Weiss, Consultant in Oncology, Clinical Prof. of Medicine, Lombardi Cancer Center; Laurie Smaldone, Sr. V.P., Global Regulatory Sciences, Bristol-Myers Squibb Co.; and Catherine Vaczy, V.P., Legal, Samuel Waksal, former CEO, and Harlan Waksal, CEO, ImClone Systems, Inc.Greenwood, James C. is the author of 'Inquiry into the Imclone Cancer-Drug Story Hearings Before the Committee on Energy and Commerce, U.S. House of Representatives' with ISBN 9780756730611 and ISBN 0756730619.